Fusion Antibodies (LON:FAB) Shares Down 6.8% – Here’s What Happened

Fusion Antibodies plc (LON:FAB)’s share price was down 6.8% during trading on Tuesday . The company traded as low as GBX 7.23 ($0.09) and last traded at GBX 7.50 ($0.10). Approximately 1,222,605 shares were traded during trading, a decline of 10% from the average daily volume of 1,362,271 shares. The stock had previously closed at GBX 8.05 ($0.10).

Fusion Antibodies Price Performance

The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The company has a fifty day moving average price of GBX 8.38 and a two-hundred day moving average price of GBX 5.93. The company has a market cap of £6.56 million, a P/E ratio of -1.57 and a beta of 0.49.

Fusion Antibodies Company Profile

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.